Pre-eclampsia is associated with complement pathway activation in the maternal and fetal circulation, and placental tissue.
Blakey, Hannah Sun, Ruyue Xie, Long Russell, Rebecca Sarween, Nadia Hodson, James Hargitai, Beata Marton, Tamas A H Neil, Desley Wong, Edwin
Blakey, Hannah
Sun, Ruyue
Xie, Long
Russell, Rebecca
Sarween, Nadia
Hodson, James
Hargitai, Beata
Marton, Tamas
A H Neil, Desley
Wong, Edwin
Citations
Altmetric:
Affiliation
Other Contributors
Publication date
2023-04-21
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
Objectives: Pre-eclampsia (PE) is a leading cause of obstetric morbidity, with no definitive therapy other than delivery. We aimed to compare complement markers in maternal and fetal circulation, and placental tissue, between women with PE and healthy pregnant controls.
Study design: Maternal and umbilical cord blood was tested for iC3b, C3, C4, properdin, Ba and C5b-9, and placental tissue for C3d, C4d, C9 and C1q, from women with PE (n = 34) and healthy pregnant controls (n = 33). Maternal properdin and Ba tests were repeated in a separate validation cohort (PE n = 35; healthy pregnant controls n = 35).
Main outcome measures: Complement concentrations in maternal and umbilical cord blood, and placental immunohistochemical complement deposition.
Results: Women with PE had significantly lower concentrations of properdin (mean: 4828 vs 6877 ng/ml, p < 0.001) and C4 (mean: 0.20 vs 0.31 g/l, p < 0.001), and higher Ba (median: 150 vs 113 ng/ml, p = 0.012), compared to controls. After controlling for gestational age at blood draw, average properdin concentration was 1945 ng/ml lower in PE vs controls (95 % CI: 1487-2402, p < 0.001). Of the cord blood markers assessed, only Ba differed significantly between PE and controls (median: 337 vs 233 ng/ml, p = 0.004). C4d staining of the syncytiotrophoblast membrane was increased in PE vs controls (median immunoreactivity score 3 vs 0, p < 0.001). Maternal properdin and C4 were significantly negatively correlated with placental C4d staining.
Conclusions: Our data confirm excessive placental complement deposition associated with significant concurrent changes in maternal and fetal circulating complement biomarkers in PE. Inhibition of complement activation is a potential therapeutic target.
Citation
Blakey H, Sun R, Xie L, Russell R, Sarween N, Hodson J, Hargitai B, Marton T, A H Neil D, Wong E, Sheerin NS, Bramham K, Harris CL, Knox E, Drayson M, Lipkin G. Pre-eclampsia is associated with complement pathway activation in the maternal and fetal circulation, and placental tissue. Pregnancy Hypertens. 2023 Jun;32:43-49. doi: 10.1016/j.preghy.2023.04.001. Epub 2023 Apr 21.
Type
Article